Psykey Company Description

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.

The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.

Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes.

The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021.

Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Psykey, Inc.

Country	United States
Founded	2002
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	6
CEO	Michael Maher

Contact Details

Address: 17 Belfield Road Toronto, Nevada M9W1E8 Canada
Phone	888 376 8258
Website	psykeyworld.com

Stock Details

Ticker Symbol	CEOS
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US1500431077
SIC Code	3669

Key Executives

Name	Position
Michael Maher	Interim Chief Executive Officer
Amar Singh Bhatal	Co-Founder, President, Secretary and Director
Sukhinderpaul Kalsi	Co-Founder, Chief Financial Officer, Treasurer and Director
Jacqueline Rae Danforth	Compliance Officer and Accountant
Mark Perkell	Vice President and General Counsel
John Gustin	Head of Global Business Development